Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label continuation study of adalimumab in moderate to severe chronic plaque psoriasis
2005-000095-41Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Apr 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of adalimumab in psoriasis, sponsored by Abbott Laboratories. Primary endpoints: Efficacy variables in Period O, Long-term safety and 3 more. Started Apr 2005; status: completed.
02
Drugs
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2005-000095-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000095-41.